X4 Pharmaceuticals logo
X4 Pharmaceuticals XFOR
$ 0.61 1.02%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

X4 Pharmaceuticals Balance Sheet 2011-2024 | XFOR

Annual Balance Sheet X4 Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-43.5 M -88.2 M -47.6 M -44.7 M -103 M -22.9 M -64.6 M 12.3 M 435 K - - - -

Long Term Debt

54.6 M 32.3 M 33.1 M 33.2 M 20.1 M 7.89 M 9.92 M 10.1 M 4.7 M - - - -

Long Term Debt Current

1.1 M 1.2 M 1.08 M 786 K 898 K - - - - - - - -

Total Non Current Liabilities

- - - - 22 M 9.01 M 11.9 M 52.1 M 37.2 M - - - -

Total Current Liabilities

22.9 M 22.3 M 14 M 11.9 M 9.45 M 5.4 M - - - - - - -

Total Liabilities

96.2 M 81.5 M 52.8 M 50.1 M 31.5 M 14.4 M 22.5 M 64.2 M 43.8 M - - - -

Deferred Revenue

- - - - - 737 K 694 K 504 K 430 K - - - -

Retained Earnings

-478 M -377 M -283 M - -132 M -135 M -92.3 M -58.4 M -35.4 M - - - -

Total Assets

147 M 156 M 117 M 123 M 161 M 36 M 81.3 M 7.6 M 9.51 M - - - -

Cash and Cash Equivalents

99.2 M 122 M 81.8 M 78.7 M 126 M 8.13 M 26.7 M 3.43 M - - - - -

Book Value

51.1 M 74.1 M 64.4 M 72.8 M 129 M 21.6 M 58.7 M -56.6 M -34.3 M - - - -

Total Shareholders Equity

51.1 M 74.1 M 64.4 M 72.8 M 129 M -77.1 M -44.5 M -56.6 M - - - - -

All numbers in USD currency

Quarterly Balance Sheet X4 Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

75 M 75 M 55 M 55 M 55 M 32.5 M 32.5 M 32.5 M 32.5 M - 32.5 M 32.5 M 32.5 M 32.5 M 32.5 M 33.2 M 32.5 M 32.5 M 32.5 M 20 M 20 M 22.2 M 14.2 M 8.31 M 8.31 M 8.31 M 8.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

119 M 116 M 111 M 96.2 M 106 M 106 M 72.7 M 81.5 M 51.6 M - 49.9 M 52.8 M 51.8 M 52.4 M 54.1 M 50.1 M 50.1 M 50.1 M 50.1 M 31.5 M 31.5 M 31.5 M 31.5 M 21.6 M 21.6 M 21.6 M 21.6 M 22.5 M 22.5 M 22.5 M 22.5 M - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-476 M -439 M -530 M -478 M -459 M -456 M -401 M -377 M -348 M - -305 M -283 M -253 M -232 M -213 M -194 M -194 M -194 M -194 M -132 M -132 M -132 M -132 M -79.2 M -79.2 M -79.2 M -79.2 M -92.3 M -92.3 M -92.3 M -92.3 M - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

178 M 211 M 112 M 147 M 173 M 173 M 124 M 156 M 113 M - 99.6 M 117 M 121 M 142 M 161 M 123 M 123 M 123 M 123 M 161 M 161 M 161 M 161 M 9.94 M 9.94 M 9.94 M 9.94 M 81.3 M 81.3 M 81.3 M 81.3 M - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

97.4 M 147 M 60.5 M 99.2 M 133 M 137 M 94.4 M 122 M 81.1 M 48.7 M 67.7 M 81.8 M 77.7 M 95.2 M 115 M 78.7 M 78.7 M 78.7 M 78.7 M 126 M 126 M 126 M 126 M 8.13 M 8.13 M 8.13 M 8.13 M 26.7 M 76.8 M 76.8 M 76.8 M 15.2 M - - - 7.1 M - - - - - - - - - - - - - - - - - - -

Book Value

59.6 M 94.5 M 1.04 M 51.1 M 67.6 M 67.5 M 51.7 M 74.1 M 61.8 M - 49.7 M 64.4 M 68.7 M 89.2 M 107 M 72.8 M 72.8 M 72.8 M 72.8 M 129 M 129 M 129 M 129 M -11.7 M -11.7 M -11.7 M -11.7 M 58.7 M 58.7 M 58.7 M 58.7 M - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

59.6 M 94.5 M 1.04 M 51.1 M 67.6 M 67.5 M 51.7 M 74.1 M 61.8 M 30.1 M 49.7 M 64.4 M 68.7 M 87.3 M 105 M 72.8 M 72.8 M 72.8 M 72.8 M 129 M 129 M 129 M 129 M -77.1 M -77.1 M -77.1 M -77.1 M -44.5 M 58.7 M 58.7 M 58.7 M -23.1 M - - - -34.3 M - - - - - - - - - - - - - - - - - - -

All numbers in USD currency